Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy — Gregg L. Friedman (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Shared by
Gregg L. Friedman
Johns Hopkins University
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Article
2025
en
Related publications
Article
2012
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Friedman
Article
2024
Abstract A004: Broad and synergistic anti-tumor effects of small-molecule inhibitors of hypoxia inducible factors when paired with immune checkpoint blockade
Shaima Salman
,
Tina Huang
,
Yousang Hwang
,
Anmol Kumar
,
Dominic Dordai
,
Authors
Gregg L. Friedman
Johns Hopkins University
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Alexander D. MacKerell
,
Gregg L. Friedman
Article
2016
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Luana Schito
,
Gregg L. Friedman
Article
2022
Hypoxia-inducible factors: cancer progression and clinical translation
Elizabeth E. Wicks
,
Gregg L. Friedman
Article
2013
Role of Hypoxia-Inducible Factors in Breast Cancer Metastasis
Daniele M. Gilkes
,
Gregg L. Friedman
Discussion(0)
No comments yet. Be the first to comment.